Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]

Affiliations

• ¹ Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018 Montichiari, Brescia, Italy.
• ² Department of Neurology and Psychiatry, Sapienza University, Viale Dell'Università 30, 00185 Rome, Italy.
• ³ Department of Biomedical and NeuroMotor Sciences (DIBINEM), Alma Mater Studiorum, Università di Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB), "UOSI Riabilitazione Sclerosi Multipla", Via Altura 3, 40139 Bologna, Italy.
• ⁴ SCDO Neurologia 2, Centro di Riferimento Regionale Sclerosi Multipla, AOU San Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Torino, Italy.
• ⁵ Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 48, 20132 Milan, Italy.
• ⁶ Multiple Sclerosis Centre, Clinica Neurologica, AOU "Maggiore della Carità" Novara, Corso Mazzini 18, 28100 Novara, Italy.
• ⁷ Centro Ricerca Emato-oncologia AIL (CREA), Diagnostics Department, Spedali Civili of Brescia, Piazzale Spedali Civili, 1, 25123 Brescia, Italy.
• ⁸ Department of Neuroradiology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 20132 Milan, Italy.
• ⁹ Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018 Montichiari, Brescia, Italy. Electronic address: ruggero.capra@gmail.com.